Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Preparation and Characterization of Self-assembled Glycol Chitosan Hydrogels Containing Palmityl-acylated Exendin-4 for Extended Hypoglycemic Action

  • Received : 2011.05.15
  • Accepted : 2011.06.03
  • Published : 2011.06.20
Download PDF
⟨ Previous Next ⟩

Abstract

Injectable chitosan hydrogels have attracted great potential due to sustained-release property and safety. Here, palmityl-acylated glycol chitosan (Pal-GC) was used to generate physically cross-linked hydrogels by virtue of hydrophobic attraction of linear fatty carbons. Glycol chitosan was chemically modified with N-hydroxysuccinimide-activated palmitic acid in dimethylsulfoxide (DMSO) containing dimethylaminopyridine. Through a series of preparation steps of (i) dialysis with DMSO, (ii) addition of palmityl-acylated exendin-4 (Ex4-C16), and (iii) dialysis with water, Pal-GC was self-assembled to form physically cross-linked hydrogels entrapped with Ex4-C16. The Pal-GC derivative was analyzed by using 1H NMR, and the surface morphology of Pal-GC hydrogels formed was examined by scanning electron microscopy. Also, the hypoglycemic effect induced by Pal-GC hydrogels containing Ex4-C16 (250 nmol/kg) was evaluated in non-fasted type 2 diabetic db/db mice and compared with GC hydrogels containing native Ex4 at the same dose. Results showed that palmityl group was successfully conjugated with the amines of glycol chitosan, and that Pal-GC efficiently generated the hydrogels formation. Moreover, Pal-GC hydrogels containing Ex4-C16 was found to greatly prolong the hypoglycemia duration (~ 4 days). This was due to the dual-functions of the palmityl groups present in both GC and exendin-4 such as hydrophobic attraction and plasma albumin-binding. We consider this new type of self-assembled GC hydrogels loaded with Ex4-C16 would be a promising long-acting sustained-release system with anti-diabetic property.

Keywords

References

  1. Bentley, M.D., Roberts, M.J., Harris, J.M., 1998, Reductive amination using poly(ethylene glycol) acetaldehyde hydrate generated in situ: applications to chitosan and lysozyme. J. Pharm.Sci. 87, 1446-1449. https://doi.org/10.1021/js980064w
  2. Bhattarai, N., Gunn, J., Zhang, M., 2010. Chitosan-based hydrogels for controlled, localized drug delivery. Adv. Drug Deliv. Rev. 62, 83-99. https://doi.org/10.1016/j.addr.2009.07.019
  3. Caliceti, P., Veronese, F.M., 2003. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. Adv. Drug Deliv. Rev. 55, 1261-1277. https://doi.org/10.1016/S0169-409X(03)00108-X
  4. Chae, S.Y., Jin, C.H., Shin, J.H., Son, S., Kim, T.H., Lee, S., Youn, Y.S., Byun, Y., Lee M.S., Lee, K.C., 2010. Biochemical, pharmaceutical and therapeutic properties of long-acting lithocholic acid derivatized exendin-4 analogs. J. Control. Release 142, 206-213. https://doi.org/10.1016/j.jconrel.2009.10.025
  5. Chiu, Y.L., Chen, S.C., Su, C.J., Hsiao, C.W., Chen, Y.M., Chen, H.L., Sung, H.W., 2009. pH-triggered injectable hydrogels prepared from aqueous N-palmitoyl chitosan: In vitro characteristics and in vivo biocompatibility. Biomaterials. 30, 4877-4888. https://doi.org/10.1016/j.biomaterials.2009.05.052
  6. Chuang, V.T., Kragh-Hansen, U., Otagiri, M., 2002. Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm. Res. 19, 569-577. https://doi.org/10.1023/A:1015396825274
  7. Hoffman, A.S., 2002. Hydrogels for biomedical applications. Adv. Drug Deliv. Rev. 54, 3-12. https://doi.org/10.1016/S0169-409X(01)00239-3
  8. Jeong, B., Kim, S.W., Bae, Y.H., 2002. Thermosensitive sol-gel reversible hydrogels. Adv. Drug Deliv. Rev. 54, 37-51. https://doi.org/10.1016/S0169-409X(01)00242-3
  9. Nakatsuka, S., Andrady, A.L., 1992. Permeability of vitamin B12 in chitosan membranes-effect of cross-linking with poly(vinyl alcohol) on permeability. J. Appl. Polym. Sci. 44, 17-28. https://doi.org/10.1002/app.1992.070440103
  10. Patel, V.R., Amiji, M.M., 1996. Preparation and characterization offreeze-dried chitosan-poly(ethylene oxide) hydrogels for site specific antibiotic delivery in the stomach. Pharm. Res. 13, 588-593. https://doi.org/10.1023/A:1016054306763
  11. Peppas, N.A., Bures, P., Leobandung, W., Ichikawa, H., 2000. Hydrogels in pharmaceutical Formulations. Eur. J. Pharm. Biopharm. 50, 27-46. https://doi.org/10.1016/S0939-6411(00)00090-4
  12. Peppas, N.A., Hilt, J.Z., Khademhosseini, A., Langer, R., 2006a. Hydrogels in biomedical applications: from fundamentals to nanobiotechnology. Adv. Mater. 18, 1345-1360. https://doi.org/10.1002/adma.200501612
  13. Peppas , N.A., Hilt, J.Z., Khademhosseini, A., Langer, R., 2006b. Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv. Mater. 18, 1345-1360. https://doi.org/10.1002/adma.200501612
  14. Potta, T., Chun, C., Song, S.C., 2010. Injectable, dual cross-linkable polyphosphazene blend hydrogels Original Research Article. Biomaterials. 31, 8107-8120. https://doi.org/10.1016/j.biomaterials.2010.07.029
  15. Qingpu, H., Paul, A.D.B., Kevin, M.S., 2004. Injectable scaffolds for tissue regeneration. J. Mater. Chem. 14, 1915-1923. https://doi.org/10.1039/b401791a
  16. Sophie, R., Van,T., Gert, S., Wim, E.H., 2008. In situ gelling hydrogels for pharmaceutical and biomedical applications Review Article. Int. J. Pharm. 355, 1-18. https://doi.org/10.1016/j.ijpharm.2008.01.057

Cited by

  1. Chitosan and its derivatives as vehicles for drug delivery vol.24, pp.2, 2017, https://doi.org/10.1080/10717544.2017.1399305